» Articles » PMID: 34881055

Structural Predictive Model of Presenilin-2 Protein and Analysis of Structural Effects of Familial Alzheimer's Disease Mutations

Overview
Journal Biochem Res Int
Publisher Wiley
Specialty Biochemistry
Date 2021 Dec 9
PMID 34881055
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease manifests itself in brain tissue by neuronal death, due to aggregation of -amyloid, produced by senile plaques, and hyperphosphorylation of the tau protein, which produces neurofibrillary tangles. One of the genetic markers of the disease is the gene that translates the presenilin-2 protein, which has mutations that favor the appearance of the disease and has no reported crystallographic structure. In view of this, protein modeling is performed using prediction and structural refinement tools followed by an energetic and stereochemical characterization for its validation. For the simulation, four reported mutations are chosen, which are Met239Ile, Met239Val, Ser130Leu, and Thr122Arg, all associated with various functional responses. From a theoretical analysis, a preliminary bioinformatic study is made to find the phosphorylation patterns in the protein and the hydropathic index according to the polarity and chemical environment. Molecular visualization was carried out with the Chimera 1.14 software, and the theoretical calculation with the hybrid quantum mechanics/molecular mechanics system from the semi-empirical method, with Spartan18 software and an AustinModel1 basis. These relationships allow for studying the system from a structural approach with the determination of small distance changes, potential surfaces, electrostatic maps, and angle changes, which favor the comparison between wild-type and mutant systems. With the results obtained, it is expected to complement experimental data reported in the literature from models that would allow us to understand the effects of the selected mutations.

Citing Articles

Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City.

Sosa A, Brucki S, Crivelli L, Lopera F, Acosta D, Acosta-Uribe J Alzheimers Dement. 2024; 20(7):5009-5026.

PMID: 38801124 PMC: 11247679. DOI: 10.1002/alz.13850.


Alzheimer's Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links.

Zhang M, Hu S, Sun X Life (Basel). 2023; 13(2).

PMID: 36836731 PMC: 9963274. DOI: 10.3390/life13020373.


The Vascular-Immune Hypothesis of Alzheimer's Disease.

Mehta R, Mehta R Biomedicines. 2023; 11(2).

PMID: 36830944 PMC: 9953491. DOI: 10.3390/biomedicines11020408.


Computer-Aided Screening and Revealing Action Mechanism of Green Tea Polyphenols Intervention in Alzheimer's Disease.

Wang M, Yang X, Gao Y, Han W Foods. 2023; 12(3).

PMID: 36766162 PMC: 9914464. DOI: 10.3390/foods12030635.


Structural Protein Effects Underpinning Cognitive Developmental Delay of the p.Phe233del Mutation Modelled by Artificial Intelligence and the Hybrid Quantum Mechanics-Molecular Mechanics Framework.

Lopez-Rivera J, Rodriguez-Salazar L, Soto-Ospina A, Estrada-Serrato C, Serrano D, Chaparro-Solano H Brain Sci. 2022; 12(7).

PMID: 35884678 PMC: 9313109. DOI: 10.3390/brainsci12070871.


References
1.
Li Y, Zhang Y . REMO: A new protocol to refine full atomic protein models from C-alpha traces by optimizing hydrogen-bonding networks. Proteins. 2009; 76(3):665-76. PMC: 2771173. DOI: 10.1002/prot.22380. View

2.
. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995; 11(2):219-22. DOI: 10.1038/ng1095-219. View

3.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

4.
Perluigi M, Barone E, Di Domenico F, Butterfield D . Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways. Biochim Biophys Acta. 2016; 1862(10):1871-82. DOI: 10.1016/j.bbadis.2016.07.005. View

5.
Cai Y, An S, Kim S . Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders. Clin Interv Aging. 2015; 10:1163-72. PMC: 4507455. DOI: 10.2147/CIA.S85808. View